PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, "M-type") K currents in neurons.

Mouse / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31272312 ↗2019Reported benefit

Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, "M-type") K currents in neurons.

MouseTBIControlled cortical impactC57BL/6Systemic administration30 min after traumatic brain injury

Model: Controlled closed-cortical impact blunt traumatic brain injury

Systemic retigabine given 30 min after injury reduced the post-injury cascade including spontaneous seizures, chemo-convulsant susceptibility, metabolic stress, inflammation, blood-brain barrier breakdown and cell death.

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.